Casey's General Stores CEO on why consumers are focused on value
"Coming out of Covid, when we had some supply chain challenges and inflation took off, I think that was a shock to the system," Rebelez said. "And then you compound that with interest rates going up, it really shook people loose. And so now, even if you have money, people are questioning why they're paying for something that they don't think the value is quite there."
Casey's is an Iowa-based convenient store chain that operates primarily in the Midwest and the South. The company posted an earnings and revenue beat Monday night, and the stock surged during Tuesday's session to reach a new 52-week high, finishing the up 11.59%.
In addition to fuel and groceries, the chain promotes a variety of pizzas and other food items. According to Rebelez, the pizza is made from scratch and has helped the brand earn a "cult following." He also said Casey's receives "strong ratings on value" from higher-income consumers.
Rebelez discussed Casey's expansion plans, citing an acquisition made last fall that allowed the company to open new locations in Texas. Casey's could open thousands of new stores, he said. He added that in its home state of Iowa, which has a population of about $3 million, Casey's already has 550 million locations.
"The population of Texas is 30 million people, and we have 170 stores there," Rebelez said. "We have white space for days in, in Texas."
Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest smarter.Disclaimer
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness
We recently published . Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc. (NYSE:MRK)'s shares have lost 16% year-to-date as investors continue to be disappointed by the dropping revenue of its GARDASIL HPV drug in China. They are also worried about the patent expiration of the firm's mega cancer drug KEYTRUDA and wondering whether Merck & Co., Inc. (NYSE:MRK) will be able to follow up with an equally successful successor. However, the shares did gain 3% this week after Pfizer announced that its bladder cancer drug PADCEV improves survival rates when paired with KEYTRUDA. Cramer was impressed as he commented: 'Look at Merck. I mean, Saint Merck. What a tough, what a tough.' Photo by National Cancer Institute on Unsplash Here are his earlier comments about Merck & Co., Inc. (NYSE:MRK): 'Well, this GARDASIL, when is it? The Chinese are not really helping them sell, because you would have thought the Chinese would. . .and then you've got the KEYTRUDA, you know the patent cliff coming up. . .it's amazing, but they are talking about their animal division. When you're talking about your animal division you don't have enough [inaudible] to talk.' While we acknowledge the potential of MRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
3 minutes ago
- Yahoo
monday.com Ltd. (MNDY) Is Part Of The 'Enterprise Software Revulsion,' Says Jim Cramer
We recently published . Ltd. (NASDAQ:MNDY) is one of the stocks Jim Cramer recently discussed. Ltd. (NASDAQ:MNDY) is an Israeli software company that develops and provides enterprise-focused products. Its shares have lost 22.8% year-to-date on the back of a stunning 29.8% drop in August, which underscores the brutal sentiment surrounding enterprise software in the age of AI. Ltd. (NASDAQ:MNDY) earnings were a negative catalyst, as even though the firm beat analyst and revenue estimates, the fact that its Q3 midpoint revenue guidance of $312 million missed analyst estimates of $313 million along with a conservative guidance hike and a weak Q2 beat were devastating for the shares. Here is what Cramer said about Ltd. (NASDAQ:MNDY): 'What I have here in my hand, Josh Baer . . .who upgrades, Morgan Stanley upgrades after, brutal, look at that, that's actually a decline. Now, why was Monday down? Monday is a company that does work processes. . . it's like a junior ServiceNow if you want to. Now it happened to have the misfortune of reporting on the same day that Ben Reitzes introduced the AI eats software, now actually a year and a half ago he actually coined that term so I don't know why people are thinking that he just did it. But this is all part of this, enterprise software revulsion. We don't want enterprise software, we want semiconductors. . .and I think that people should recognize that these companies are all being viewed as, let's say carrion, because what's happened is this that you can develop your own stuff that is better. Copyright: dolgachov / 123RF Stock Photo 'Look I just got to tell you I think that all these stocks are going to be shrinking in price-to-earnings multiples. You shouldn't be thinking about misses.' While we acknowledge the potential of MNDY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
3 minutes ago
- Yahoo
Taiwan Semiconductor Manufacturing Company Limited (TSM) Is Worried About High Construction Costs Of US Plants, Says Jim Cramer
We recently published . Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the stocks Jim Cramer recently discussed. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) isn't a frequent feature of Cramer's morning show despite the fact that the firm is the world's largest contract chip manufacturer. His previous remarks about the company have pointed out that most of its revenue gains are due to orders from NVIDIA. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is playing a key role in bringing chip manufacturing to the US through its multi-billion-dollar facilities in Arizona. However, the firm has faced some troubles, such as rising costs and cultural differences. Here is what Cramer said about Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM): 'By the way, Taiwan Semi is saying it costs a huge amount of money to build here versus Arizona.' the-main-processor-3334336_1280 Previously, the CNBC TV host discussed Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM)'s earnings and financial performance: 'Yeah look, Taiwan Semi reports overnight. It's an unbelievably good number but understand it's really unbelievably good number because of high performance computing. In other words, it's a good number because of NVIDIA. While we acknowledge the potential of TSM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
